Novavax Inc. Stock Slips 3.8%, Underperforms Peers
Dow Jones2026/09/15 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. slipped 3.8% to $9.23 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.8% to 25,981.57 and Dow Jones Industrial Average falling 0.6% to 52,093.11.
The stock's fall snapped a two-day winning streak.
Novavax Inc. closed 22.9% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.3% to $267.20, Pfizer Inc. fell 0.6% to $27.55, and Merck & Co. Inc. fell 0.15% to $143.79.
Trading volume totaled 3.3 million, compared to the 50-day average of 4.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 15, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "new Bond King" Gundlach warns: The next recession may trigger a US debt crisis, and US Treasury bonds will no longer be a safe haven.
The "new bond king" Jeffrey Gundlach has warned that the next round of economic downturn in the United States could trigger a debt crisis, pushing long-term U.S. Treasury yields sharply higher. This would break the decades-old conventional belief that bonds are always a safe haven during economic turbulence.
Nvidia (NVDA.US) further strengthens AI infrastructure by investing $2 billion in Brookfield (BAM.US) Global AI Fund, which aims to raise $10 billion.
Nvidia has invested $2 billion in the Global Artificial Intelligence Infrastructure Fund under Brookfield Asset Management.
LCNB Chief Wealth Officer Michael Miller to Retire
Loop Industries to Evaluate Alternatives, India Joint Venture Financing
Crypto prices
More
